Technical innovations in peritoneal dialysis (PD), now used widely for the long-term
treatment of ESRD, have significantly reduced therapy-related complications, allowing …

Peritoneal dialysis (PD) is a renal replacement therapy for patients with end-stage renal
disease that is equivalent to hemodialysis with respect to adequacy, mortality, and other …

Lay summary Peritoneal dialysis (PD) uses the peritoneal membrane for dialysis. The
peritoneal membrane is a thin layer of tissue that lines the abdomen. The lining is used as a …

Peritoneal dialysis (PD) is a form of renal replacement and is based on the use of the
peritoneum as a semipermeable membrane across which ultrafiltration and diffusion take …

Background: During peritoneal dialysis (PD), the peritoneum is exposed to bioincompatible
dialysis fluids that cause epithelial-to-mesenchymal transition of mesothelial cells, fibrosis …

Long-term peritoneal dialysis can lead to morphological and functional changes in the
peritoneum. Although the range of morphological alterations is known for the peritoneal …

Encapsulating peritoneal sclerosis (EPS) is recognized as a serious complication of
continuous peritoneal dialysis. A preliminary diagnosis of EPS is usually based on clinical …

The success of peritoneal dialysis (PD) is dependent on the structural and functional
integrity of the peritoneal membrane. The mesothelium lines the peritoneal membrane and …

This comprehensive update on the management of encapsulating peritoneal sclerosis
incorporates insights gained from recently published findings and the accumulated …

The characteristic features of chronic peritoneal injury with peritoneal dialysis (PD) are
submesothelial fibrosis and neoangiogenesis. Transforming growth factor (TGF) β and …